About
Looking for more information?
Contact our responsive and friendly client services team any time.
(03) 9028 2888
clients@freshequities.com
Investor presentation - Bionomics Limited
Bionomics Limited
Health
Bionomics Limited (BNO) is an Australian biopharmaceutical company focused on the discovery and development of cancer, central nervous system disorders such as anxiety, depression and Alzheimer's Disease. BNO partners with pharmaceutical companies to get the drugs through the later stages of development and into the market.
Read moreMarket Cap
$110.29m
Price at Close
$0.15
4w avg. Volume
359.40k
4w avg. Turnover
$55.90k
Announcements
| announcement | t+2 movement | date |
|---|---|---|
| -3.03% | 19 Jan 2021 |
| +3.45% | 17 Jan 2021 |
| 0.00% | 07 Jan 2021 |
| 0.00% | 03 Jan 2021 |
| +10.71% | 18 Dec 2020 |
| +8.00% | 24 Nov 2020 |
| -3.85% | 20 Nov 2020 |
| -3.85% | 20 Nov 2020 |
| -3.85% | 19 Nov 2020 |
| +8.33% | 18 Nov 2020 |
Market Data
Current Price
$0.15
52WK HIGH
$0.19
52WK LOW
$0.03
1YR RETURN
+111.27%
1YR RETURN VS. SECTOR
+71.00%
90 DAY RETURN
+25.00%
ASX RANK
853
/2,048
SECTOR RANK
73
/168
SHARES OUTSTANDING
735.25m
Bionomics Limited
Health
Bionomics Limited (BNO) is an Australian biopharmaceutical company focused on the discovery and development of cancer, central nervous system disorders such as anxiety, depression and Alzheimer's Disease. BNO partners with pharmaceutical companies to get the drugs through the later stages of development and into the market.
Read moreMarket Cap
$110.29m
Price at Close
$0.15
4w avg. Volume
359.40k
4w avg. Turnover
$55.90k
ASX:BNO is not raising right now
Want to invest?
Contact Us
(03) 9028 2888
clients@freshequities.com
Address
Level 7, 388 Bourke St
Melbourne VIC 3000
Australia